NDAORALTABLET
Approved
Oct 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
VASERETIC (enalapril maleate and hydrochlorothiazide) by Bausch + Lomb. Approved for thiazide diuretic [epc]. First approved in 1986.
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VASERETIC is an oral combination tablet containing enalapril maleate (an ACE inhibitor) and hydrochlorothiazide (a thiazide diuretic) approved in 1986 for hypertension management. It works by simultaneously inhibiting angiotensin-converting enzyme and promoting sodium/water excretion to reduce blood pressure. The fixed-dose combination targets patients requiring dual antihypertensive therapy for optimized BP control.
$0.081MPart D
LOE ApproachingDeclining
Minimal commercial momentum with only $81K in Part D spending and 101 claims in 2023, indicating a legacy asset with contracted team focus on maintenance rather than expansion.
Mechanism of Action
Pharmacologic Class:
Thiazide Diuretic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VASERETIC as a pharma professional positions you in legacy portfolio management with minimal growth trajectory and limited cross-functional opportunities. This role is best suited for professionals seeking stability in a mature, low-competition environment rather than career acceleration or innovation-focused development.
Brand Manager (Maintenance)Field Sales (Generics)
Worked on VASERETIC at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.